ArticlePathology oncology research : POR2021

Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia, Focusing on Long Term Cytopenias Before and After the Era of Targeted Therapies.

Róbert Szász et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.